Aktive Positionen von Michel Kaczorek
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Synt:em SA
Synt:em SA Pharmaceuticals: MajorHealth Technology Synt:em SA researches and manufactures drugs for the treatment of pain and cancer. The company specializes in the discovery and development of Central Nervous System (CNS) medicines and novel therapeutics for the treatment diseases. It was founded in 1995 by Michel Kaczorek and Caroline Roussel and is headquartered in Nîmes, France. | Vorstandsvorsitzender | 01.01.1995 | - |
CliniGenetics SA
CliniGenetics SA Pharmaceuticals: MajorHealth Technology CliniGenetics SA discovers and develops novel therapeutics for the treatment of cardiovascular, cerebrovascular, and lower limb ischemic diseases. The firm identifies and develops new pathways and products for the treatment of vascular diseases. CliniGenetics was founded in 2000 and is headquartered in Nimes, France. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Michel Kaczorek
Statistik
International
Frankreich | 3 |
Operativ
Chief Executive Officer | 1 |
Director/Board Member | 1 |
Sektoral
Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Synt:em SA
Synt:em SA Pharmaceuticals: MajorHealth Technology Synt:em SA researches and manufactures drugs for the treatment of pain and cancer. The company specializes in the discovery and development of Central Nervous System (CNS) medicines and novel therapeutics for the treatment diseases. It was founded in 1995 by Michel Kaczorek and Caroline Roussel and is headquartered in Nîmes, France. | Health Technology |
CliniGenetics SA
CliniGenetics SA Pharmaceuticals: MajorHealth Technology CliniGenetics SA discovers and develops novel therapeutics for the treatment of cardiovascular, cerebrovascular, and lower limb ischemic diseases. The firm identifies and develops new pathways and products for the treatment of vascular diseases. CliniGenetics was founded in 2000 and is headquartered in Nimes, France. | Health Technology |
- Börse
- Insiders
- Michel Kaczorek
- Erfahrung